Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CytoMed Therapeutics Limited Ordinary Shares
GDTCCurrent price
2.31 USD
-0.15 USD (-5.92%)
Last closed
2.41 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
33 119 784 USD
Yield for 12 month
-43.09 %
1Y
3Y
5Y
10Y
15Y
GDTC
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company was incorporated in 2018 and is headquartered in Singapore. Address: 1 Commonwealth Lane, No. 08-22, Singapore, Singapore, 149544
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
+290 829 USD
Last Year
+275 080 USD
Current Quarter
–
Last Quarter
+64 013 USD
Current Year
+288 694 USD
Last Year
+268 488 USD
Current Quarter
-93 636 USD
Last Quarter
+63 334 USD
Key Figures GDTC
1 year
3 years
5 years
10 years
EBITDA
-3 120 472 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-17.44 %
PEG Ratio
–
Return On Equity TTM
-26.26 %
Wall Street Target Price
5 USD
Revenue TTM
447 695 USD
Book Value
0.88 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-21.1 %
Dividend Yield
–
Gross Profit TTM
355 192 USD
Earnings per share
-0.22 USD
Diluted Eps TTM
-0.22 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GDTC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GDTC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GDTC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
73.9785
Enterprise Value EBITDA
-4.452
Price Book MRQ
4.2219
Financials GDTC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GDTC
For 52 weeks
1.2 USD
5.5 USD
50 Day MA
1.78 USD
Shares Short Prior Month
118 899
200 Day MA
2.16 USD
Short Ratio
10.61
Shares Short
116 076
Short Percent
6.81 %
BeatStart